vaccine

New Trial: Investigational Breast Cancer Vaccine Plus Immune Therapy

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.

July 31, 2020

Announcements DCI Research

Researchers Find Simpler, More Effective Cancer Vaccine Approach

Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models.

November 13, 2019

DCI Research

Vaccine for HER2 Breast Cancer Shows Early Promise

A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast canc...

March 11, 2019

DCI Research Announcements